Shares of Insperity (NSP), a leading human resources and business performance solutions provider, plummeted 5.51% in pre-market trading on Friday following the release of its disappointing second-quarter earnings report and lowered full-year guidance.
The company reported adjusted earnings per share (EPS) of $0.26 for the quarter ended June 30, significantly below the analyst consensus estimate of $0.43 and down from $0.86 in the same period last year. Revenue for the quarter came in at $1.658 billion, slightly missing the expected $1.662 billion but showing a 3% increase from the previous year.
Insperity's performance was impacted by higher-than-expected benefits costs, primarily driven by elevated pharmacy trends and large claim activities. This resulted in a decrease in gross profit from $260 million in Q2 2024 to $223 million in Q2 2025. Adding to investors' concerns, the company lowered its full-year 2025 adjusted EPS guidance to a range of $1.81 to $2.51, down from the previous outlook of $2.23 to $3.28. This reduction in guidance, coupled with the earnings miss, likely contributed to the sharp decline in the stock price.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。